Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation

被引：0
|
作者：
Nicolas -Xavier Bonne
Rabih Aboukais
Marc Baroncini
Audrey Hochart
Pierre Leblond
Franck Broly
Frédérique Dubrulle
Jean-Paul Lejeune
Christophe Vincent
机构：
[1] CHRU de Lille,Department of Otology and Neurotology
[2] CHRU de Lille,Department of Neurosurgery
[3] Centre Oscar Lambret,Department of Pediatric Oncology
[4] CHRU de Lille,Department of Genetic
[5] CHRU Lille,Service de Toxicologie, Génopathies
[6] CHRU Lille,Department of Radiology, Hôpital Huriez
来源：
Child's Nervous System | 2016年 / 32卷
关键词：
Neurofibromatosis type 2; Vestibular schwannoma; Middle fossa; Hearing préservation; Auditory brainstem implant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2403 / 2413
页数：10
相关论文
共 50 条
  • [21] Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2
    Nowak, Arkadiusz
    Dziedzic, Tomasz
    Czernicki, Tomasz
    Kunert, Przemyslaw
    Morawski, Krzysztof
    Niemczyk, Kazimierz
    Marchel, Andrzej
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2015, 49 (05) : 295 - 301
  • [22] Optimal outcomes for hearing preservation in the management of small vestibular schwannomas
    Peng, K. A.
    Wilkinson, E. P.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2016, 130 (07) : 606 - 610
  • [23] Microsurgery for patients diagnosed with neurofibromatosis type 2 complicated by vestibular schwannomas: Clinical experience and strategy for treatments
    Chen, Li-Hua
    Zhang, Hong-Tian
    Xu, Ru-Xiang
    Zhang, Li
    Li, Wen-De
    Sun, Kai
    MEDICINE, 2018, 97 (17)
  • [24] Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation
    Fu Zhao
    Bo Wang
    Zhijun Yang
    Qiangyi Zhou
    Peng Li
    Xingchao Wang
    Jing Zhang
    Junting Zhang
    Pinan Liu
    Journal of Neuro-Oncology, 2018, 138 : 417 - 424
  • [25] Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation
    Zhao, Fu
    Wang, Bo
    Yang, Zhijun
    Zhou, Qiangyi
    Li, Peng
    Wang, Xingchao
    Zhang, Jing
    Zhang, Junting
    Liu, Pinan
    JOURNAL OF NEURO-ONCOLOGY, 2018, 138 (02) : 417 - 424
  • [26] Age at Onset and Presenting Symptoms of Neurofibromatosis Type 2 as Prognostic Factors for Clinical Course of Vestibular Schwannomas
    Gugel, Isabel
    Grimm, Florian
    Zipfel, Julian
    Teuber, Christian
    Ernemann, Ulrike
    Kluwe, Lan
    Tatagiba, Marcos
    Mautner, Victor-Felix
    Schuhmann, Martin Ulrich
    CANCERS, 2020, 12 (09) : 1 - 12
  • [27] Options and strategies for hearing restoration in pediatric neurofibromatosis type 2
    Hossein Mahboubi
    William H. Slattery
    Gautam U. Mehta
    Gregory P. Lekovic
    Child's Nervous System, 2020, 36 : 2481 - 2487
  • [28] Options and strategies for hearing restoration in pediatric neurofibromatosis type 2
    Mahboubi, Hossein
    Slattery, William H., III
    Mehta, Gautam U.
    Lekovic, Gregory P.
    CHILDS NERVOUS SYSTEM, 2020, 36 (10) : 2481 - 2487
  • [29] Reduced dosage of bevacizumab in treatment of vestibular schwannomas in patients with neurofibromatosis type 2
    Said Farschtschi
    Philipp Kollmann
    Carsten Dalchow
    Alexander Stein
    Victor-Felix Mautner
    European Archives of Oto-Rhino-Laryngology, 2015, 272 : 3857 - 3860
  • [30] A Systematic Review of Radiosurgery Versus Surgery for Neurofibromatosis Type 2 Vestibular Schwannomas
    Chung, Lawrance K.
    Nguyen, Thien P.
    Sheppard, John P.
    Lagman, Carlito
    Tenn, Stephen
    Lee, Percy
    Kaprealian, Tania
    Chin, Robert
    Gopen, Quinton
    Yang, Isaac
    WORLD NEUROSURGERY, 2018, 109 : 47 - 58
12345